Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of$0.16. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +6.25$0.24 per share when it actually produced a loss of $0.17, delivering a surprise of +29.17%.Over the last four ...